Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio Key International (BKYI) Amortization of Deferred Charges (2018 - 2025)

Bio Key International's Amortization of Deferred Charges history spans 10 years, with the latest figure at -$47145.0 for Q3 2025.

  • For Q3 2025, Amortization of Deferred Charges fell 136.56% year-over-year to -$47145.0; the TTM value through Sep 2025 reached $108491.0, down 63.87%, while the annual FY2024 figure was $164589.0, 3.91% down from the prior year.
  • Amortization of Deferred Charges for Q3 2025 was -$47145.0 at Bio Key International, down from $84827.0 in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $171291.0 in Q4 2023 and bottomed at -$80717.0 in Q3 2023.
  • The 5-year median for Amortization of Deferred Charges is $32204.0 (2021), against an average of $32949.5.
  • The largest YoY upside for Amortization of Deferred Charges was 543.83% in 2023 against a maximum downside of 465.67% in 2023.
  • A 5-year view of Amortization of Deferred Charges shows it stood at $32204.0 in 2021, then dropped by 17.39% to $26605.0 in 2022, then skyrocketed by 543.83% to $171291.0 in 2023, then plummeted by 79.2% to $35636.0 in 2024, then crashed by 232.3% to -$47145.0 in 2025.
  • Per Business Quant, the three most recent readings for BKYI's Amortization of Deferred Charges are -$47145.0 (Q3 2025), $84827.0 (Q2 2025), and $35173.0 (Q1 2025).